Optiver Holding
VRCA icon

Optiver Holding’s Verrica Pharmaceuticals VRCA Stock Holding History

Optiver Holding’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31
Closed -$164 – 3112
2026
Q1 		$164 Hold
31
– – ﹤0.01% 2227
2025
Q4 		$258 Hold
31
– – ﹤0.01% 2337
2025
Q3 		$134 Buy
+31
New +$187 ﹤0.01% 2589

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Optiver Holding's VRCA Position: Q2 2026 in Review

Optiver Holding sold out of Verrica Pharmaceuticals (VRCA) in Q2 2026, closing a stake of 31 shares — an estimated $164 sold.

Optiver Holding first reported a position in VRCA in Q3 2025 and held it in 3 quarters. The position peaked at $258 in Q4 2025. 43 funds tracked by Wall St. Rank hold VRCA as of Q2 2026.

  • Optiver Holding reported no remaining Verrica Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Optiver Holding sold 31 Verrica Pharmaceuticals shares in Q2 2026, an estimated $164.
  • Optiver Holding first reported a position in Verrica Pharmaceuticals in Q3 2025 and held it in 3 quarters.
  • Optiver Holding's Verrica Pharmaceuticals position peaked at $258 in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.